GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool
All Semaglutide Brands India
Generic SemaglutideType 2 Diabetes
Sun Pharma logo

SematrinityGeneric semaglutide for type 2 diabetes in India 2026

by Sun Pharma · ₹750–2,000/month · DCGI approved December 2025

Active ingredient
Semaglutide (GLP-1 receptor agonist)
Indication
Type 2 Diabetes
Manufacturer
Sun Pharmaceutical Industries Ltd
DCGI status
Approved December 2025
Price (MRP)
₹750–2,000/month
Format
Multi-dose pen
Prescription
Schedule H — required

How Sematrinity compares

Sematrinity is Sun Pharma's type-2-diabetes brand of generic semaglutide, sharing the same active molecule as Noveltreat (Sun Pharma's obesity brand) but labelled and dosed for glycaemic control. Multi-dose pen format simplifies titration for endocrinologists managing T2D dose escalation.

About Sun Pharma

Sun Pharma's dual-brand strategy mirrors Novo Nordisk's Ozempic (T2D) / Wegovy (obesity) approach — same molecule, distinct branding for distinct prescribing populations. Both Sematrinity and Noveltreat received DCGI approval together in December 2025.

Who is Sematrinity for?

Sematrinity is approved in India for type 2 diabetes mellitus in adults. Typically used as add-on therapy when metformin + lifestyle aren't achieving glycaemic targets, or as first-line in T2D patients with established cardiovascular disease, obesity, or chronic kidney disease per RSSDI 2024 guidelines.

Not sure if you qualify? Take the 5-minute Indian-guideline eligibility check →

Sematrinity for specific conditions

Sematrinity for type 2 diabetes →Sematrinity and prediabetes →

Sematrinity cost in India

MRP for Sematrinity: ₹750–2,000/month. Actual pharmacy pricing varies by city, pharmacy, and channel. Online prescription pharmacies typically offer modest discounts off MRP with cold-chain delivery; hospital pharmacy pricing is usually at MRP.

Compare with all India brands: GLP-1 therapy cost in India 2026 →

Compared to other GLP-1 brands in India

Sematrinity is an Indian generic semaglutide. Same active molecule as Ozempic and Wegovy (Novo Nordisk innovator brands), with clinical efficacy that follows the molecule rather than the brand. Other Indian generics include Sundae, Noveltreat, Obeda, Semaglyn, Sembolic, and Samakind — all at similar price points.

All GLP-1 comparisons →All Indian semaglutide brands →Clinical evidence library →GLP-1 blog (India) →

Sematrinity — frequently asked questions

Is Sematrinity available in India? Is it DCGI-approved?+
Yes — Sematrinity is DCGI-approved and currently available across India. The drug received DCGI approval in December 2025 for type 2 diabetes, manufactured by Sun Pharmaceutical Industries Ltd. It is distributed through licensed retail and online prescription pharmacies and hospital pharmacies across Indian metros and most tier-2 cities. Sematrinity is a Schedule H drug — a doctor's prescription is required. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
What does Sematrinity cost in India in 2026?+
Sematrinity is priced at ₹750–2,000/month. Actual pharmacy pricing may vary by city and channel. For brand-by-brand price comparisons across all India brands, see our cost guide. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
Do I need a prescription to buy Sematrinity?+
Yes — Sematrinity is a Schedule H drug in India and can only be dispensed against a valid prescription from a registered medical practitioner. Any legitimate online prescription pharmacy will require you to upload your prescription before order fulfillment.
Who is Sematrinity for?+
Sematrinity is approved for type 2 diabetes in India. Indian guideline eligibility typically requires BMI ≥27.5 (obesity indication) or HbA1c above target on first-line therapy (T2D indication), often with comorbidities at BMI ≥25. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
How does Sematrinity compare to Ozempic and Wegovy?+
Sematrinity contains the same active molecule (semaglutide) as Ozempic and Wegovy. Clinical efficacy is comparable; the difference is brand, manufacturer support, pen design, and price. Sematrinity (₹750–2,000/month) is meaningfully cheaper than Ozempic (₹5,660+/month) or Wegovy (up to ₹16,400/month) — useful for cost-sensitive patients on long-term therapy.
Where can I buy Sematrinity in India?+
Sematrinity is a Schedule H drug — available through licensed retail and online prescription pharmacies and hospital pharmacies across India with a doctor's prescription. Always buy from a licensed pharmacy to avoid counterfeit products; never use sources that dispense without verifying a prescription. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
Official

Manufacturer announcement

Sun Pharma — Semaglutide launch announcement (March 2026)

Additional source

Sun Pharma DCGI approval PR

GLP-1 Check is informational, not a medical diagnosis. Semaglutide is a Schedule H drug in India and requires a prescription from a registered medical practitioner. Always consult a qualified physician before starting any treatment.

Are you eligible for Sematrinity?

Take the free 5-minute triage to check your GLP-1 readiness against Indian clinical guidelines.

Check My Eligibility →

Looking at other brands?

See full price comparison across all 25+ DCGI-approved brands →